HFA Premium Access

Efficacy and safety of selexipag in patients with pulmonary arterial hypertension in real-life: early results of RAMPHA study

Congress Presentation

About the speaker

Doctor Rafael Bravo-Marques

University Hospital Costa del Sol, Marbella (Spain)
0 follower

6 more presentations in this session

Myocardial work in different aetiologies of right ventricular hemodynamic overload

Speaker: Mr K. Hansen (Aarhus, DK)


Feasibility and safety of the antecubital venous access for right heart catheterization in patients with pulmonary hypertension

Speaker: Doctor J. Grade Santos (Almada, PT)


COMPERA score revised: better risk estimation to better tailor therapeutics in precapillary hypertension

Speaker: Doctor P. Alves da Silva (Lisbon, PT)


Comparison of different clinical prognostic scores in patients with pulmonary embolism and active cancer

Speaker: Doctor A. Martins (Lisbon, PT)


Dexamethasone treatment attenuates pulmonary embolism rates in severe COVID-19 disease

Speaker: Doctor P. Jirak (Salzburg, AT)


Access the full session

Focus on the right side

Speakers: Doctor R. Bravo-Marques, Mr K. Hansen, Doctor J. Grade Santos, Doctor P. Alves da Silva, Doctor A. Martins...

About the event


Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb